Literature DB >> 19779769

Optimal utilization of extended hepatic grafts.

Sherilyn Gordon Burroughs1, Ronald W Busuttil.   

Abstract

Orthotopic liver transplantation has emerged as the standard treatment for end-stage liver disease. In the United States, the number of listed patients has tripled in the last two decades. Organ availability during the same period has plateaued at approximately 6000 grafts annually, resulting in a fivefold increase in wait-list mortality. The problem is not specific to the United States; European and Asian registries report similar shortages. Donor pool expansion strategies such as the use of living donors, cadaveric split livers, and "extended criteria donors"; (ECD) are being pursued. Used judiciously, ECD grafts provide an opportunity for addressing the shortage. Although there is no universally accepted definition of ECD, the term generally refers to donor factors predisposing recipients to poor initial graft function and/or increased long-term risk. These factors include advanced donor age, hypernatremia, prolonged warm ischemic time, pressor requirement, and donation after cardiac death. The transplant community is scrutinizing all factors to evaluate the degree of risk they impart on the recipient and the extent to which grafts can be "matched"; to maintain acceptable outcomes. We review the importance of selected factors and the impact of a "matching"; strategy to minimize recipient risk while optimizing graft use.

Entities:  

Mesh:

Year:  2009        PMID: 19779769     DOI: 10.1007/s00595-008-4022-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data.

Authors:  R Mateo; Y Cho; G Singh; M Stapfer; J Donovan; J Kahn; T-L Fong; L Sher; N Jabbour; S Aswad; R R Selby; Y Genyk
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

2.  Donor-specific factors predict graft function following liver transplantation.

Authors:  P D Greig; J Forster; R A Superina; S M Strasberg; M Mohamed; L M Blendis; B R Taylor; G A Levy; B Langer
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

3.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

4.  Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation.

Authors:  Ramón Rull; Oscar Vidal; Dulce Momblan; Francisco Xavier González; Miguel Angel López-Boado; Jose Fuster; Luis Grande; Miguel Bruguera; Katiana Cabrer; Juan Carlos García-Valdecasas
Journal:  Liver Transpl       Date:  2003-04       Impact factor: 5.799

5.  Effect of nonviral factors on hepatitis C recurrence after liver transplantation.

Authors:  Andrew M Cameron; Rafik M Ghobrial; Jonathan R Hiatt; Ian C Carmody; Sherilyn A Gordon; Douglas G Farmer; Hasan Yersiz; Michael A Zimmerman; Francisco Durazo; Steve H Han; Sammy Saab; Jeffrey Gornbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

6.  New era of liver transplantation for hepatitis B: a 17-year single-center experience.

Authors:  Dean M Anselmo; Rafik M Ghobrial; Lee Chan Jung; Michael Weaver; Carlos Cao; Sammy Saab; Greg Kunder; Pauline W Chen; Douglas G Farmer; Hasan Yersiz; Angeles Baquerizo; Sunil Geevarghese; Steven H Han; Leonard Goldstein; Curtis D Holt; Jeffrey A Gornbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

Review 7.  Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.

Authors:  Janardan K Reddy; M Sambasiva Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05       Impact factor: 4.052

8.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.

Authors:  R J Ploeg; A M D'Alessandro; S J Knechtle; M D Stegall; J D Pirsch; R M Hoffmann; T Sasaki; H W Sollinger; F O Belzer; M Kalayoglu
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

9.  Liver transplantation for cystic fibrosis in adults.

Authors:  Toru Ikegami; Edmund Q Sanchez; Tadahiro Uemura; Gomathy Narasimhan; Ousama Masannat; Srinath Chinnakotla; Gregory J McKenna; Henry B Randall; Marlon F Levy; Robert M Goldstein; Goran B Klintmalm
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

10.  Correlation between donor age and the pattern of liver graft recovery after transplantation.

Authors:  H Yersiz; A Shaked; K Olthoff; D Imagawa; C Shackleton; P Martin; R W Busuttil
Journal:  Transplantation       Date:  1995-10-27       Impact factor: 4.939

View more
  10 in total

Review 1.  Development of organ-specific donor risk indices.

Authors:  Sanjeev K Akkina; Sumeet K Asrani; Yi Peng; Peter Stock; W Ray Kim; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

Review 2.  Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.

Authors:  Dronacharya Routh; Sudeep Naidu; Sanjay Sharma; Priya Ranjan; Rajesh Godara
Journal:  J Clin Exp Hepatol       Date:  2013-12-05

3.  Carbon monoxide induces hypothermia tolerance in Kupffer cells and attenuates liver ischemia/reperfusion injury in rats.

Authors:  Lung-Yi Lee; Takashi Kaizu; Hideyoshi Toyokawa; Matthew Zhang; Mark Ross; Donna B Stolz; Chao Huang; Chandrashekhar Gandhi; David A Geller; Noriko Murase
Journal:  Liver Transpl       Date:  2011-12       Impact factor: 5.799

4.  Current status of organ transplantation in Japan and worldwide.

Authors:  Norio Yoshimura; Hideaki Okajima; Hidetaka Ushigome; Seisuke Sakamoto; Masato Fujiki; Masahiko Okamoto
Journal:  Surg Today       Date:  2010-05-23       Impact factor: 2.549

Review 5.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 6.  Liver transplantation for hepatocellular carcinoma.

Authors:  Jerome Byam; John Renz; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2013-02       Impact factor: 7.293

7.  Deceased Brain Dead Donor Liver Transplantation and Utilization in the United States: Nighttime and Weekend Effects.

Authors:  Dustin J Carpenter; Mariana C Chiles; Elizabeth C Verna; Karim J Halazun; Jean C Emond; Lloyd E Ratner; Sumit Mohan
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

8.  The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.

Authors:  Vladimir J Lozanovski; Elias Khajeh; Hamidreza Fonouni; Jan Pfeiffenberger; Rebecca von Haken; Thorsten Brenner; Markus Mieth; Peter Schirmacher; Christoph W Michalski; Karl Heinz Weiss; Markus W Büchler; Arianeb Mehrabi
Journal:  Langenbecks Arch Surg       Date:  2018-08-15       Impact factor: 2.895

9.  EPOR2/βcR2-independendent effects of low-dose epoetin-α in porcine liver transplantation.

Authors:  Linus Kebschull; Leon Franz Christoph Theilmann; Annika Mohr; Wencke Uennigmann; Sandra Stoeppeler; Barbara Heitplatz; Hans-Ullrich Spiegel; Ralf Bahde; Daniel Michael Palmes; Felix Becker
Journal:  Biosci Rep       Date:  2017-12-05       Impact factor: 3.840

Review 10.  Transplant of Elderly Patients: Is There an Upper Age Cutoff?

Authors:  Claudia Cottone; Nathalie A Pena Polanco; Kalyan Ram Bhamidimarri
Journal:  Clin Liver Dis       Date:  2020-10-21       Impact factor: 6.126

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.